GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wesana Health Holdings Inc (XCNQ:WESA.X) » Definitions » Debt-to-EBITDA

Wesana Health Holdings (XCNQ:WESA.X) Debt-to-EBITDA : -0.50 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Wesana Health Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Wesana Health Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.34 Mil. Wesana Health Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.00 Mil. Wesana Health Holdings's annualized EBITDA for the quarter that ended in Dec. 2023 was C$-0.67 Mil. Wesana Health Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.50.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Wesana Health Holdings's Debt-to-EBITDA or its related term are showing as below:

XCNQ:WESA.X' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.24   Med: -0.11   Max: -0.1
Current: -0.24

During the past 4 years, the highest Debt-to-EBITDA Ratio of Wesana Health Holdings was -0.10. The lowest was -0.24. And the median was -0.11.

XCNQ:WESA.X's Debt-to-EBITDA is ranked worse than
100% of 277 companies
in the Biotechnology industry
Industry Median: 1.36 vs XCNQ:WESA.X: -0.24

Wesana Health Holdings Debt-to-EBITDA Historical Data

The historical data trend for Wesana Health Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wesana Health Holdings Debt-to-EBITDA Chart

Wesana Health Holdings Annual Data
Trend Apr20 Apr21 Dec22 Dec23
Debt-to-EBITDA
N/A - -0.10 -0.12

Wesana Health Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.06 -0.07 -0.07 -0.50

Competitive Comparison of Wesana Health Holdings's Debt-to-EBITDA

For the Biotechnology subindustry, Wesana Health Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wesana Health Holdings's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wesana Health Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Wesana Health Holdings's Debt-to-EBITDA falls into.



Wesana Health Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Wesana Health Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.335 + 0) / -2.71
=-0.12

Wesana Health Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.335 + 0) / -0.672
=-0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Wesana Health Holdings  (XCNQ:WESA.X) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Wesana Health Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Wesana Health Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Wesana Health Holdings (XCNQ:WESA.X) Business Description

Traded in Other Exchanges
Address
745 Thurlow Street, Suite 2400, Vancouver, BC, CAN, V6E 0C5
Wesana Health Holdings Inc is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. The Company is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma with the help of extensive clinical research and academic partnerships.

Wesana Health Holdings (XCNQ:WESA.X) Headlines

No Headlines